Table 1: Baseline demographics and clinical characteristics, patients and caregivers.
|
T1D PWD N = 100 |
T1D CG* N = 100 |
T2D MTI N = 100 |
T2D BI N = 100 |
||
Age, Caregivers, %1 |
|
|
|
|
||
18 - < 40 years |
19 |
20 |
9 |
12 |
||
≥ 40 - ≤ 65 years |
81 |
80 |
91 |
88 |
||
Age, Child2 |
|
|
|
|
||
1-5 years |
- |
9 |
- |
- |
||
6-11 years |
- |
42 |
- |
- |
||
12-17 years |
- |
49 |
- |
- |
||
Female, % (Adults)1 |
43 |
58 |
38 |
42 |
||
Prefer not to answer |
- |
6 |
- |
1 |
||
Relationship to Child with T1D, %1 |
|
|
|
|
||
Parent |
- |
84 |
- |
- |
||
Aunt/Uncle |
- |
10 |
- |
- |
||
Grandparent |
- |
5 |
- |
- |
||
Other Family Member |
- |
1 |
- |
- |
||
Type of Diabetes Therapy, %2 |
|
|
|
|
||
Oral therapy |
32 |
61 |
- |
1 |
||
Basal insulin |
59 |
43 |
30 |
99 |
||
Meal-time insulin |
64 |
38 |
100 |
2 |
||
Other |
2 |
8 |
3 |
3 |
||
Concomitant Chronic Health Conditions % (excluding diabetes)2 |
|
|
|
|
||
Arthritis |
12 |
8 |
24 |
32 |
||
Alzheimer's disease |
3 |
4 |
3 |
2 |
||
Asthma |
17 |
13 |
21 |
18 |
||
Cardiovascular disease |
7 |
4 |
8 |
12 |
||
Depression |
21 |
17 |
36 |
36 |
||
Heart disease |
9 |
5 |
12 |
16 |
||
Osteoporosis |
3 |
3 |
3 |
5 |
||
Other |
4 |
1 |
7 |
3 |
||
% of Patients on insulin who experienced blood sugar levels < 54 mg/dL combined with one or more symptoms of severe hypoglycemia in the last 12 months** |
95 |
96 |
90 |
86 |
||
Traditional Glucagon Kits Ever Purchased/Owned, % |
|
|
|
|
||
Glucagon Emergency Kit (Lilly) |
54 |
61 |
21 |
28 |
||
Glucagen HypoKit (Novo) |
34 |
52 |
24 |
30 |
||
Glucagon Emergency Kit (Fresenius) |
45 |
41 |
23 |
23 |
||
None |
13 |
6 |
49 |
40 |
T1D PWD: Adult Type 1 patients; T1D CG: Caregivers of pediatric Type 1 patients; T2D MTI: Adult Type 2 patients on meal-time insulin; T2D BI: Adult Type 2 patients on basal insulin (but not meal-time insulin. 1Among caregivers. 2Among patients *Reported by caregiver on behalf of child, **Self-reported